Cargando…
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertens...
Autores principales: | Adir, Yochai, Elia, Davide, Harari, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487698/ https://www.ncbi.nlm.nih.gov/pubmed/26324801 http://dx.doi.org/10.1183/16000617.0041-2015 |
Ejemplares similares
-
Recent advances in the management of pulmonary hypertension with interstitial lung disease
por: Waxman, Aaron B., et al.
Publicado: (2022) -
Rare pulmonary disease and orphan drugs: a path to the future
por: Harari, Sergio, et al.
Publicado: (2019) -
Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
por: Harari, Sergio, et al.
Publicado: (2021) -
Pulmonary hypertension and chronic lung disease: where are we headed?
por: Elia, Davide, et al.
Publicado: (2019) -
New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
por: Torre, Olga, et al.
Publicado: (2017)